IPP Bureau
Pharmanovia appoints Stephan Eder as CEO
By IPP Bureau - October 07, 2025
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Alembic and Amlan launch feed additive solutions for poultry
By IPP Bureau - October 07, 2025
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Biocon and Carnegie receive FDA tentative approval for Rifaximin tablets
By IPP Bureau - October 07, 2025
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy
Briefs: Shilpa Medicare and Medico Remedies
By IPP Bureau - October 07, 2025
Medico Remedies receives order worth US$ 1,781,000
Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
By IPP Bureau - October 07, 2025
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
FDA approves Zydus’ Deflazacort oral suspension, 22.75 mg/mL
By IPP Bureau - October 07, 2025
Deflazacort oral suspension is indicated for treating Duchenne Muscular Dystrophy in patients 5 years of age and older
HRV Pharma unveils brand mascots
By IPP Bureau - October 07, 2025
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
Merck completes acquisition of Verona Pharma
By IPP Bureau - October 07, 2025
Through this acquisition Merck has added Ohtuvayre (ensifentrine) to its growing cardio-pulmonary pipeline and portfolio
PromoCell launches custom GMP cell culture media to power next-gen cell and gene therapies
By IPP Bureau - October 07, 2025
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD unveils future of beauty at In-Cosmetics Latin America 2025
By IPP Bureau - October 07, 2025
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Molcure and Boehringer Ingelheim team up to supercharge antibody discovery with AI
By IPP Bureau - October 07, 2025
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Lonza expands cell and gene therapy portfolio
By IPP Bureau - October 07, 2025
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Health Secretary Srivastava chairs meeting with states/UTs on quality and rational use of cough syrups
By IPP Bureau - October 06, 2025
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
FDA supports new ANDA prioritization pilot to support US generic drugs
By IPP Bureau - October 06, 2025
